e-learning
resources
ERS Research Seminars
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What new biomarkers are on the horizon for severe exacerbations?
P. Burgel (Paris, France)
Source:
Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Number:
17
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Burgel (Paris, France). What new biomarkers are on the horizon for severe exacerbations?. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Does past experience predict future exacerbations in adults with asthma?
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020
Year: 2021
Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010
Are severe and moderate exacerbations different entities?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021
How can we better treat infective exacerbations of COPD?
Source: Annual Congress 2012 - Prevention and treatment of infective exacerbations of COPD
Year: 2012
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Is CRP a reliable diagnostic tool for infective exacerbations of COPD?
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
Source: Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021
Year: 2021
Impact of stable state symptoms on the future burden of COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Clinical clustering of COPD patients is useful to predict future COPD exacerbations
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
Recommended new therapies for severe asthma and the future
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014
How can treatable traits be used in severe exacerbations?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021
Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021
Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013
A new early predictive index for hospitalisation in acute exacerbations of asthma
Source: Annual Congress 2008 - Mechanical ventilation and airway management
Year: 2008
Prediction of future COPD exacerbations - DOSE index or a history of exacerbations?
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept